Notice2022-19393
Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 8, 2022
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Curia Wisconsin, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 173 (Thursday, September 8, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 173 (Thursday, September 8, 2022)]
[Notices]
[Pages 55041-55042]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19393]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1076]
Bulk Manufacturer of Controlled Substances Application: Curia
Wisconsin, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Wisconsin, Inc., has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 7, 2022. Such persons may also file a written request for a
hearing on the application on or before November 7, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 25, 2022, Curia Wisconsin, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024-0000, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide............... 7315 I
Tetrahydrocannabinols.................... 7370 I
4-Bromo-2,5-dimethoxyphenethylamine...... 7392 I
3,4-Methylenedioxyamphetamine............ 7400 I
3,4-Methylenedioxymethamphetamine........ 7405 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Dimethyltryptamine....................... 7435 I
Psilocybin............................... 7437 I
Psilocyn................................. 7438 I
Methylphenidate.......................... 1724 II
Nabilone................................. 7379 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
[[Page 55042]]
The company plans to bulk manufacture the listed controlled
substances for the purpose of analytical reference standards or for
sale to its customers. In reference to the drug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture as
synthetic. No other activity for this drug code is authorized for this
registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-19393 Filed 9-7-22; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on September 8, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.